The Genetic basis of alcohol and drug actions / edited by John C. Crabbe, Jr. and R. Adron Harris.
Material type: TextPublication details: Plenum Press, c1991.Description: xvi,383pISBN:- 9780306438684 :
- 0306438682
- Alcohol -- Physiological effect
- Pharmacogenetics -- Animal models
- Alcoholism -- Animal models
- Drug abuse -- Animal models
- Alcoholism -- Genetic aspects
- Drug abuse -- Genetic aspects
- Alcohol -- Physiological effects
- Alcoholism -- genetics
- Pharmacogenetics
- Substance Abuse -- genetics
- Disease Models, Animal
- Substance-Related Disorders -- genetics
- Neurosciences
- Humans Effects of Drugs
- 615.78 CRA
Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Long Loan | TUS: Midlands, Main Library Athlone General Lending | 615.78 CRA (Browse shelf(Opens below)) | 1 | Available | 114170 |
Includes bibliographical references and index.
The tools of pharmacogenetics / Gerald E. McClearn -- Behavioral studies of genetic differences in alcohol action / Tamara J. Phillips and John C. Crabbe -- Neurochemical studies of genetic differences in alcohol action / Andrea M. Allan and R. Adron Harris -- Electrophysiological studies of genetic differences in alcohol action / Thomas V. Dunwiddie -- Molecular biological approaches to studies of alcohol-metabolizing enzymes / Howard J. Edenberg -- Studies of genetic differences in response to opioid drugs / J.K. Belknap and L.A. O'Toole -- Genetics of biozodiazephines, barbiturates, and anesthetics / Edward J. Gallaher and John C. Crabbe -- Genetic differences in response to cocaine and stimulant drugs / Thomas W. Seale -- Genetic studies of nicotinic and muscarinic agents / Allan C. Collins and Michael J. Marks -- Genetic differences in the N-methyl-D-aspartate receptor: effects of ethanol and phencyclidine / Paula L. Hoffman ... [et al.].
After a review of the tools of pharmacogenetics, contributors critically evaluate the burgeoning literature within limits determined by the editors: the focus is narrowed to those drugs that have demonstrated abuse potential; reviews are restricted to genetic animal models; and issues of drug metabolism are not systematically reviewed, given that s.